|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Investment portfolio: | ||||||||||||||||||||
| Fixed income available-for-sale | ||||||||||||||||||||
| Fixed income | ||||||||||||||||||||
| Short-Term Investments | ||||||||||||||||||||
| Total fixed income available-for-sale | ||||||||||||||||||||
| Equity securities, at fair value (cost 2026 - $16,360; 2025 - $16,286) | ||||||||||||||||||||
| Other invested assets, at cost | ||||||||||||||||||||
| Total investment portfolio | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash and cash equivalents | ||||||||||||||||||||
| Accrued investment income | ||||||||||||||||||||
| Reinsurance recoverable on loss reserves | ||||||||||||||||||||
| Reinsurance recoverable on paid losses | ||||||||||||||||||||
| Premiums receivable | ||||||||||||||||||||
| Home office and equipment, net | ||||||||||||||||||||
| Deferred insurance policy acquisition costs | ||||||||||||||||||||
| Deferred income taxes, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities and Shareholders’ Equity | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Loss reserves | ||||||||||||||||||||
| Unearned premiums | ||||||||||||||||||||
| Senior notes | ||||||||||||||||||||
| Convertible junior subordinated debentures | ||||||||||||||||||||
| Federal tax credits payable | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Shareholders’ equity: | ||||||||||||||||||||
| Common stock | ||||||||||||||||||||
| Paid-in capital | ||||||||||||||||||||
| Treasury stock, at cost | ||||||||||||||||||||
| Accumulated other comprehensive income (loss), net of tax | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total Shareholders’ Equity | ||||||||||||||||||||
| Total Liabilities and Shareholders’ Equity | ||||||||||||||||||||
Loading...
